In addition, EGFR activation is also related to aggressiveness in malignant CMC, including increased angiogenesis, large tumor sizes, tumor necrosis, higher mitotic rates, advanced clinical stages, and malignancy [14]. The gene discussed is EGFR; the disease is neoplasm.